JSIAMA Biopharmaceuticals Overview

  • Year Founded
  • 2021

Year Founded

  • Status
  • Private

  • Latest Deal Type
  • Early Stage VC

  • Latest Deal Amount
  • $6.89M

  • Investors
  • 3

JSIAMA Biopharmaceuticals General Information

Description

Developer of clinical-stage biopharmaceuticals designed for innovative immunotherapies targeting respiratory diseases, including cancer. The company focuses on the discovery and development of novel drug platforms, providing healthcare professionals with therapeutic solutions for conditions like allergic rhinitis, allergic dermatitis, respiratory infections, and vaccine adjuvants.

Contact Information

Website
www.iamabio.com
Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Corporate Office
  • 3F, Building E, Phase II, Sino-Danish Ecological Life Science Industrial Park
  • No. 3-1, Xinjinhu Road, Jiangbei New District
  • Nanjing, Jiangsu 210000
  • China
+86 025
Primary Industry
Biotechnology
Other Industries
Drug Discovery
Vertical(s)
Corporate Office
  • 3F, Building E, Phase II, Sino-Danish Ecological Life Science Industrial Park
  • No. 3-1, Xinjinhu Road, Jiangbei New District
  • Nanjing, Jiangsu 210000
  • China
+86 025

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

JSIAMA Biopharmaceuticals Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
2. Early Stage VC 26-Mar-2025 $6.89M Completed Generating Revenue
1. Early Stage VC 29-Jul-2022 Completed Generating Revenue
To view JSIAMA Biopharmaceuticals’s complete valuation and funding history, request access »

JSIAMA Biopharmaceuticals Investors (3)

Investor Name Investor Type Holding Investor Since Participating Rounds
Zhejiang Hisun Pharmaceutical Company Corporation Minority
Hangzhou Tailong Venture Capital Partnership Growth/Expansion Minority
Prosperico Ventures Venture Capital Minority
To view JSIAMA Biopharmaceuticals’s complete investors history, request access »

JSIAMA Biopharmaceuticals FAQs

  • When was JSIAMA Biopharmaceuticals founded?

    JSIAMA Biopharmaceuticals was founded in 2021.

  • Where is JSIAMA Biopharmaceuticals headquartered?

    JSIAMA Biopharmaceuticals is headquartered in Nanjing, China.

  • What industry is JSIAMA Biopharmaceuticals in?

    JSIAMA Biopharmaceuticals’s primary industry is Biotechnology.

  • Is JSIAMA Biopharmaceuticals a private or public company?

    JSIAMA Biopharmaceuticals is a Private company.

  • What is the current valuation of JSIAMA Biopharmaceuticals?

    The current valuation of JSIAMA Biopharmaceuticals is .

  • What is JSIAMA Biopharmaceuticals’s current revenue?

    The current revenue for JSIAMA Biopharmaceuticals is .

  • How much funding has JSIAMA Biopharmaceuticals raised over time?

    JSIAMA Biopharmaceuticals has raised $6.89M.

  • Who are JSIAMA Biopharmaceuticals’s investors?

    Zhejiang Hisun Pharmaceutical Company, Hangzhou Tailong Venture Capital Partnership, and Prosperico Ventures have invested in JSIAMA Biopharmaceuticals.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process